Skip to main content
. 2019 Aug 29;6(6):e609. doi: 10.1212/NXI.0000000000000609

Figure 3. Glutamine antagonist JHU083 does not affect dendritic cell (DC) activation.

Figure 3

Bone marrow–derived DCs were activated with LPS and treated with JHU-083 daily for 72 hours. No dose of JHU-083 affected DC activation as measured by % CD86+CD40+ of the CD11c+ population using ordinary 1-way analysis of variance with Sidak multiple comparison test. Data are mean ± standard error of the mean.